Evidence map›Paper›PMID 35462543›Full record

ArticleBMC infectious diseases2022

Association between Mycobacterium tuberculosis genotype and diabetes mellitus/hypertension: a molecular study.

Shengqiong Guo, Shiguang Lei, Prasit Palittapongarnpim, Edward McNeil, Angkana Chaiprasert, Jinlan Li, Huijuan Chen, Weizheng Ou, Komwit Surachat, Wan Qin and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Effectiveness of centralized hospitalization treatment on transmission in household contacts of pulmonary tuberculosis patients: a contact-traced study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Shengqiong GuoGuizhou Provincial Center for Disease Control and Prevention, Guiyang, China.
Shiguang Lei *Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China.
Prasit PalittapongarnpimDepartment of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
Edward McNeilDepartment of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Angkana ChaiprasertDepartment of Research and Development Affairs, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Jinlan Li *Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China.
Huijuan ChenGuizhou Provincial Center for Disease Control and Prevention, Guiyang, China.
Weizheng OuGuiyang Public Health Clinical Center, Guiyang, China.
Komwit SurachatMolecular Evolution and Computational Biology Research Unit, Faculty of Science, Prince of Songkla University, Songkhla, Thailand.
Wan QinGuiyang Public Health Clinical Center, Guiyang, China.
Siyu ZhangLiupanshui Center for Disease Control and Prevention, Liupanshui, China.
Rujuan LuoLiupanshui Center for Disease Control and Prevention, Liupanshui, China.
Virasakdi Chongsuvivatwong *Department of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand. cvirasak@medicine.psu.ac.th.
Prince of Songkla University · THGuizhou Center for Disease Control and Prevention · CNLiupanshui Normal University · CNShanghai Public Health Clinical Center · CNMahidol University · THSiriraj Hospital · TH

Funding

TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II: Promotion of Diversity, Equity and Inclusion (DEI)D43TW009522 · FIC · PRINCE OF SONGKLA UNIVERSITY · PI Virasakdi Chongsuvivatwong · 2015 to 2026
$3.0M
FIC NIH HHS D43 TW009522Guizhou Science and Technology Department [2020]1Y355Innovative Research Group Project of the National Natural Science Foundation of China 2019Ministry of Education TEH-AC 054/2017
6 · The paper itself

Abstract

backgroundA paucity of studies focused on the genetic association that tuberculosis (TB) patients with non-communicable diseases (NCDs) are more likely to be infected with Mycobacterium tuberculosis (MTB) with more potent virulence on anti-TB drug resistance than those without NCDs. The study aimed to document the predominant genotype, determine the association between MTB genotypes and NCD status and drug resistance.

methodsWe conducted a molecular study in 105 TB patients based on a cross-sectional study focused on the comorbid relationship between chronic conditions and TB among 1773 subjects from September 1, 2019 to August 30, 2020 in Guizhou, China. The participants were investigated through face-to-face interviews, followed by NCDs screening. The DNA of MTB isolates was extracted prior to genotyping using 24 loci MIRU-VNTR. The subsequent evaluations were performed by phylogenetic trees, combined with tests of statistical power, Chi-square or Fisher and multivariate logistic regression analysis.

resultsThe Beijing family of Lineage 2 (East Asia) was the predominant genotype accounting for 43.8% (46/105), followed by Lineage 4 (Euro-America) strains, including Uganda I (34.3%, 36/105), and the NEW-1 (9.5%, 10/105). The proportion of Beijing strain in patients with and without NCDS was 28.6% (8/28) and 49.4% (38/77), respectively, with a statistical power test value of 24.3%. No significant association was detected between MTB genotype and NCD status. A low clustering rate (2.9%) was identified, consisting of two clusters. The rates of global, mono-, poly- and multi-drug resistance were 16.2% (17/105), 14.3% (15/105), 1.0% (1/105) and 4.8% (5/105), respectively. The drug-resistant rates of rifampicin, isoniazid, and streptomycin, were 6.7% (7/105), 11.4% (12/105) and 5.7% (6/105), respectively. Isoniazid resistance was significantly associated with the Beijing genotype of Lineage 2 (19.6% versus 5.1%).

conclusionsThe Lineage 2 East Asia/Beijing genotype is the dominant genotype of the local MTB with endogenous infection preponderating. Not enough evidence is detected to support the association between the MTB genotype and diabetes/hypertension. Isoniazid resistance is associated with the Lineage 2 East Asia/Beijing strain.

Indexed as

Diabetes MellitusHypertensionMycobacterium tuberculosisNoncommunicable DiseasesTuberculosisTuberculosis, Multidrug-ResistantCross-Sectional StudiesGenotypeHumansIsoniazidPhylogenyIsoniazidAssociationCOVID-19Drug resistanceGenotypeLineageMIRU-VNTRNCDTuberculosis

Identifiers

PMID35462543
PMCPMC9035274
OpenAlexW4224317181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.